Hdfc Bank Ltd (HDB) 74.04 $HDB HDFC Bank Has Returned

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hdfc Bank Ltd (HDB) 74.04 $HDB

HDFC Bank Has Returned 28.7% Since SmarTrend Recommendation (HDB)
Comtex SmarTrend(R) - Fri Sep 02, 1:14PM CDT
SmarTrend identified an Uptrend for HDFC Bank (NYSE:HDB) on March 2nd, 2016 at $56.49. In approximately 6 months, HDFC Bank has returned 28.70% as of today's recent price of $72.71.
HDB: 74.04 (+1.19)

Look for Shares of HDFC Bank to Potentially Pullback after Yesterday's 1.25% Rise
Comtex SmarTrend(R) - Tue Aug 30, 2:42PM CDT
HDFC Bank (NYSE:HDB) traded in a range yesterday that spanned from a low of $71.51 to a high of $72.23. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $71.84 on volume of 544,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HDB: 74.04 (+1.19)

Watch for HDFC Bank to Potentially Pullback After Gaining 1.25% Yesterday
Comtex SmarTrend(R) - Tue Aug 30, 2:40PM CDT
HDFC Bank (NYSE:HDB) traded in a range yesterday that spanned from a low of $71.51 to a high of $72.23. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $71.84 on volume of 544,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HDB: 74.04 (+1.19)

HDFC Bank Shares Up 26.6% Since SmarTrend's Buy Recommendation (HDB)
Comtex SmarTrend(R) - Fri Aug 26, 12:43AM CDT
SmarTrend identified an Uptrend for HDFC Bank (NYSE:HDB) on March 2nd, 2016 at $56.49. In approximately 6 months, HDFC Bank has returned 26.63% as of today's recent price of $71.54.
HDB: 74.04 (+1.19)

Uptrend Call Working As HDFC Bank Stock Rises 21.4% (HDB)
Comtex SmarTrend(R) - Thu Aug 11, 12:53AM CDT
SmarTrend identified an Uptrend for HDFC Bank (NYSE:HDB) on March 2nd, 2016 at $56.49. In approximately 5 months, HDFC Bank has returned 21.37% as of today's recent price of $68.57.
HDB: 74.04 (+1.19)

After Yesterday's Decline of 2.11%, HDFC Bank Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 10, 2:26PM CDT
HDFC Bank (NYSE:HDB) traded in a range yesterday that spanned from a low of $68.12 to a high of $69.13. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $69.48 on volume of 514,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HDB: 74.04 (+1.19)

Look for Shares of HDFC Bank to Potentially Rebound after Yesterday's 2.11% Sell Off
Comtex SmarTrend(R) - Wed Aug 10, 2:24PM CDT
HDFC Bank (NYSE:HDB) traded in a range yesterday that spanned from a low of $68.12 to a high of $69.13. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $69.48 on volume of 514,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HDB: 74.04 (+1.19)

Upgrade Alert for HDFC Bank (HDB)
Comtex SmarTrend(R) - Wed Aug 03, 3:05AM CDT
HDFC Bank (NYSE:HDB) was upgraded from Neutral to Buy at Goldman Sachs today. The stock closed yesterday at $69.29 on volume of 758,000 shares, above average daily volume of 649,000. Potential upside of 6.8% exists for HDFC Bank, based on a current level of $69.29 and analysts' average consensus price target of $74.00. The stock should find initial support at its 50-day moving average (MA) of $59.73 and further support at its 200-day MA of $59.53.
HDB: 74.04 (+1.19)

HDFC Bank Limited Form 20-F Available Online
BusinessWire - Fri Jul 29, 3:47PM CDT
HDFC Bank Limited (NYSE: HDB) filed its Form 20-F for the year ended March 31, 2016 on July 29, 2016. Filings made by HDFC Bank Limited with the SEC are available from the SEC's EDGAR database via the direct link to its website located under "About Us/SEC Filings" on HDFC Bank's website, or via www.sec.gov. Shareholders/Members of the Bank may also write to Mr. Sanjay Dongre, Executive Vice President (Legal) & Company Secretary, HDFC Bank Limited, 2nd Floor, Process House, Kamala Mills Compound, Lower Parel (West), Mumbai 400013, India, sanjay.dongre@hdfcbank.com, requesting a hard copy of the completed audited financial statements free of charge.
HDB: 74.04 (+1.19)

Stocks Coverage on the Financial Sector -- GAMCO Global Gold, Natural Resources & Income Trust, Apollo Global Management, First Bancorp, and HDFC Bank
PR Newswire - Mon Jun 20, 7:35AM CDT
On Friday, June 17, 2016, the NASDAQ Composite ended the trading session at 4,800.34, down 0.92%; the Dow Jones Industrial Average edged 0.33% lower, to finish at 17,675.16; and the S&P 500 closed at 2,071.22, down 0.33%. However, five out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: GAMCO Global Gold, Natural Resources & Income Trust (NYSEMKT: GGN), Apollo Global Management LLC (NYSE: APO), First Bancorp (NYSE: FBP), and HDFC Bank Ltd (NYSE: HDB). Learn more about these stocks by accessing their free trade alerts at:
APO: 18.51 (-0.39), HDB: 74.04 (+1.19), FBP: 4.77 (-0.23), GGN: 6.50 (+0.09)

TD Bank's (TD) Q2 Earnings & Revenues Up Y/Y, Costs Rise
Zacks Equity Research - Zacks Investment Research - Mon May 30, 6:37AM CDT
The Toronto-Dominion Bank (TD), also known as TD Bank, announced its fiscal second-quarter 2016 (ended Apr 30) adjusted earnings of C$1.20 per share, which were up 5% year over year.
TD: 45.66 (+0.39), RY: 63.51 (+0.74), HDB: 74.04 (+1.19), CM: 80.75 (+0.49)

Credit Suisse (CS) Posts Q1 Loss Amid Tough Backdrop
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:29AM CDT
Credit Suisse reported dismal first-quarter 2016 results. Net loss attributable to shareholders came in at CHF 302 million, which is a significant deterioration from net income recorded in the year-ago quarter.
BCS: 9.13 (-0.18), HDB: 74.04 (+1.19), CS: 13.15 (-0.12), DB: 14.46 (-0.44)

HSBC (HSBC) Q1 Earnings Down Amid Challenging Backdrop
Zacks Equity Research - Zacks Investment Research - Tue May 03, 5:37AM CDT
HSBC reported dismal first-quarter 2016 results. Challenging operating backdrop was the primary reason for decline in profit.
BCS: 9.13 (-0.18), HDB: 74.04 (+1.19), HSBC: 38.33 (-0.32), DB: 14.46 (-0.44)

ICICI Bank (IBN) Down 4% as Provisions Hit Q4 Earnings
Zacks Equity Research - Zacks Investment Research - Mon May 02, 6:16AM CDT
ICICI Bank (IBN) was down nearly 4% on NYSE following the release of fourth-quarter fiscal 2016 results due to concerns over weak global economic environment that led the company to undertake 'prudent measure' to account for future increase in delinquencies.
IBN: 8.23 (+0.35), HDB: 74.04 (+1.19), HSBC: 38.33 (-0.32), DB: 14.46 (-0.44)

HDFC Bank (HDB) Earnings Up Y/Y in Q4, Stock Rises 1%
Zacks Equity Research - Zacks Investment Research - Mon Apr 25, 8:08AM CDT
ADRs of HDFC Bank Ltd. (HDB) were up nearly 1% following the release of its fourth-quarter fiscal 2016 (ended Mar 31). Net profit was INR33.74 billion ($0.50 billion), up 20.2% year over year.
BCS: 9.13 (-0.18), IBN: 8.23 (+0.35), HDB: 74.04 (+1.19), HSBC: 38.33 (-0.32)

Itau Unibanco (ITUB) Q4 Earnings Rise on Top-Line Growth
Zacks Equity Research - Zacks Investment Research - Tue Feb 02, 9:50AM CST
Driven by strong top-line performance, Brazil's Itau Unibanco Holding S.A. (ITUB) reported fourth-quarter 2015 recurring earnings of R$5.8 billion ($1.5 billion), up 1.8% year over year.
MTU: 5.49 (-0.15), HDB: 74.04 (+1.19), DB: 14.46 (-0.44), ITUB: 11.56 (+0.25)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
USFCR Wins 2026 Award for Federal Contracting Services

Updated Category News Views 7

Award-Winning Federal Contracting Strategies News from Clearwater, Florida: US Federal Contractor Registration (USFCR) just bagged the 2026 nod from Gov Business Review as the Federal Contracting Services of the Year. Now that's a feather in the cap worth talking about. This isn't some hallway compliment, folks. It's a signal that they've nailed how to get businesses...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 3

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 28

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 5

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 4

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading

Top 5 Most Recently Viewed Articles

BioSig Technologies Updates on Merger and Share Issuance Plans

Updated Category News Views 169

BioSig Technologies Provides Merger Update LOS ANGELES and VANCOUVER, British Columbia — BioSig Technologies, Inc. (NASDAQ: BSGM), recently provided a significant update regarding its merger with Streamex Exchange Corporation. The recent developments aim to clarify the status of the merger and ensure all shareholders are informed. Details of the Merger Finalization The...

Continue Reading
Al Hurra Cuts Jobs and Merges Iraq Channel Amid Budget Cuts

Updated Category News Views 136

Al Hurra Faces Major Workforce Reductions The parent organization of the Arabic language broadcaster Al Hurra has announced significant layoffs, resulting in the elimination of 160 positions. This decision comes in the wake of a 20% budget cut mandated by the U.S. Congress, as revealed by the company’s CEO in a message to staff. Understanding the Budget Cuts Dr. Jeffrey...

Continue Reading
Strategies for Success in Hinge Research Institute's 2025 Study

Updated Category News Views 627

Innovative Strategies Highlighted in Hinge Research's 2025 Study Hinge Research Institute stands at the forefront of research on professional services growth. With its recent 10th Annual High Growth Study, the institute has delivered crucial insights into how successful firms thrive in today’s rapidly evolving market. The study not only illustrates the growth potential...

Continue Reading
Psyence Biomed Celebrates Milestones in Psilocybin Development

Updated Category News Views 125

Recent Developments in Psyence Biomed's Journey In a significant update shared by Psyence Biomedical Ltd. (Nasdaq: PBM), the company has showcased its achievements, reflecting a positive trajectory in the realm of psychedelic-based therapeutics. Highlights from the update included the impressive valuation of their stake in PsyLabs, strong clinical trial progress, and a...

Continue Reading
Rugby Resources Limited Expands Private Placement Offerings

Updated Category News Views 146

Rugby Resources Limited Expands Private Placement Opportunities Rugby Resources Ltd. (TSX-V: RUG) has announced an important development regarding its private placement offering. Responding to high subscriber demand, the company's board has authorized an increase in the number of available units, raising the offering from 60 million units to an impressive 81.84 million...

Continue Reading